Intracerebral interleukin-1β impairs response to tumor invasion: Involvement of adrenal catecholamines

Brain Research

Volumn 816, Issue 1, 1999, Pages 200-208

  Hodgson, Deborah M ^a   Yirmiya, Raz ^c   Chiappelli, Francesco ^a   Taylor, Anna N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Catecholamine; IL 1; MADB106; NK cell; Tumor

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOSTERONE; INTERLEUKIN 1BETA; NADOLOL; NORADRENALIN; OXIDOPAMINE; PHENTOLAMINE; ADRENERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 1;

ADENOCARCINOMA; ADRENALECTOMY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CONTROLLED STUDY; CYTOKINE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUNG CLEARANCE; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ADRENAL GLAND; ANIMAL; CELL CULTURE; CELLULAR IMMUNITY; DRUG EFFECT; FISCHER 344 RAT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; LUNG TUMOR; METABOLISM; METASTASIS; PHYSIOLOGY;

ADRENAL GLANDS; ADRENALECTOMY; ADRENERGIC ANTAGONISTS; ANIMALS; CATECHOLAMINES; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, CELLULAR; INTERLEUKIN-1; LUNG NEOPLASMS; MALE; NADOLOL; NEOPLASM INVASIVENESS; OXIDOPAMINE; PHENTOLAMINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; SYMPATHETIC NERVOUS SYSTEM; TUMOR CELLS, CULTURED;

EID: 0033573585     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01185-8     Document Type: Article

References (62)

1. B.L. Anderson, W.B. Farrer, D. Golden-Kreutz, L.A Kutz, R. MacCallum, M.E. Courtney, R. Glaser, Stress and immune responses after surgical treatment for regional breast cancer, J. Natl. Canc. Inst. 90 (1998) 1, 30-36.
2. Bailey P.T., Abeles F.B., Hauer E.C., Mapes C.A. Intracerebroventricular administration of leukocyte endogenous mediators (LEM) in the rat. Proc. Soc. Exp. Biol. Med. 153:1976;419-423.
3. Ballin A., Gershon V., Tanay A., Brener J., Weizman A., Meytes D. The antidepressant fluvoxamine increases natural killer cell counts in cancer patients. Israel J. Med. Sci. 33:1997;720-723.
4. Barlozzari T., Leonhardt J., Wiltrout R.H., Herberman R.B., Reynolds C.W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol. 134:1985;2783-2789.
5. Ben-Eliyahu S., Page G.G. In vivo assessment of natural killer cell activity in rats. Prog. Neuroendocrinol. 5:1992;199-214.
6. Ben-Eliyahu S., Page G.G., Yirmiya R., Taylor A.N. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nature Med. 2:1996;457-460.
7. Ben-Eliyahu S., Yirmiya R., Liebeskind J., Taylor A.N., Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav. Immunol. 5:1991;193-205.
8. Ben-Eliyahu S., Yirmiya R., Page G., Weiner H., Tan A., Taylor A.N., Liebeskind J.C. Stress-induced sympathetic activation suppresses blood natural killer cytotoxicity and increases metastatic spread in rats: mediation by adrenal epinephrine. Soc. Neurosci. Abstr. 17:1991;327.165.
9. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of IL-1 on pituitary cells. Science. 238:1987;519-521.
10. Besedovsky H., del Rey A.D., Sorkin E., Dinarello C.A. Immunological feedback between IL-1 and glucocorticoid hormones. Science. 233:1986;652-654.
11. Besedovsky H.O., del Rey A. Immune neuro-endocrine interactions: facts and hypotheses. Endocrine Rev. 17:1996;64-102.
12. J.J. Cohen, L.S. Crnic, Glucocorticoids, stress and the immune response, in: D. Webb (Ed.), Immunopharmacology and the Regulation of Leukocyte Function, Marcel Dekker, New York, 1982, pp. 61-91.
13. Cunnick J.E., Lysle D.T., Kucinski B.J., Rabin B.S. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral β-adrenergic receptors. Pharmacol. Biochem. Behav. 36:1990;645-651.
14. Dascombe M.J., Rothwell N.J., Sagay B.O., Stock M.J. Pyrogenic and thermogenic effects of interleukin-1 beta in the rat. Am. J. Physiol. 256:1989;E7-E11.
15. J. de Champlain, P. Gauthier, G. Porlier, M.-R. van Ameringen, R.A. Nadeau, Compensatory mechanisms following peripheral chemical sympathectomy, in: G. Jonnson, T. Malmfors, C.H. Sachs (Eds.), Chemical Tools in Catecholamine Research, Vol. 1, North-Holland, Amsterdam, 1975, pp. 231-237.
16. DeSimoni M.G., Seroni M., DeLuigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of IL-1 induces high circulating levels of IL-6. J. Exp. Med. 171:1990;1773-1778.
17. Dobbs C.M., Vasquez M., Glaser R., Sheridan J.F. Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 48:1993;151-160.
18. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 43:1988;429-435.
19. Feldman R.D., Hunninghake G.W., McArdle W.L. B-adrenergic receptor mediated suppression of interleukin-2 receptors in human lymphocytes. J. Immunol. 139:1987;3355-3359.
20. Felsner P., Hofer D., Rinner I., Potta S., Korsatko W., Shauenstein K. Adrenergic suppression of peripheral blood T cell reactivity in the rat. J. Neuroimmunol. 57:1995;27-34.
21. S.Y. Felten, D.L. Felten, Innervation of lymphoid tissue, in: R. Ader, D.L. Felten, N. Cohen (Eds.), Psychoneuroimmunology, 2nd edn., Academic Press, San Diego, 1991.
22. Gillis S., Crabtree G.R., Smith K.A. Glucocorticoid-induced inhibition of T-cell growth factor production: 1. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 123:1979;1624-1638.
23. A. Gorbman, H.A. Bern, A Textbook of Comparative Endocrinology, Wiley, New York, 1962.
24. Hadden J.W., Hadden E.M., Middleton E. Lymphocyte blast transformation: 1. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol. 1:1970;583-595.
25. Haefeli W.E., Bargetzi M.J., Starnes F., Blaschke T.F., Hoffman B.B. Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1β in humans. J. Immunother. 13:1993;136-140.
26. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 89:1989;334-341.
27. Herbert I., Cohen S. Depression and immunity: a meta-analytic review. Psychol. Bull. 113:1993;472-486.
28. Hodgson D.M., Yirmiya R., Chiappelli F., Taylor A.N. Intracerebral HIV glycoprotein (gp120) enhances tumor metastasis via centrally released interleukin-1. Brain Research. 781:1998;244-251.
29. Hu P.-F., Hultin L.E., Hultin P., Hausner M.A., Hirji K., Jewett A., Bonavida B., Detels R., Giorgi J.V. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+ CD56+ cells and expansion of a population of CD16 dim CD56- cells with low lytic activity. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:1995;331-340.
30. Irwin M. Brain corticotropin-releasing-hormone and interleukin-1β induces suppression of specific antibody production. Endocrinology. 133:1993;1352-1360.
31. Jacobson L., Akana S.F., Cascio C.S., Scribner K., Shinsako J., Dallman M.F. The adrenocorticol system responds slowly to removal of corticosterone in the absence of concurrent stress. Endocrinology. 124:1989;2144-2152.
32. Jacobson L., Akana S.F., Cascio C.S., Shinsako J., Dallman M.F. Circadian increases in plasma corticosterone permit normal termination of ACTH responses to stress. Endocrinology. 122:1988;1343-1351.
33. Jewett A., Bonavida B. Target-induced anergy of natural killer cytotoxic function is restricted to NK-target conjugate set. Cell. Immunol. 160:1995;91-97.
34. Jewett A., Cavalcanti M., Bonavida B. Pivotal role of endogenous TNFa in the induction of funtional inactivation and apoptosis in NK cells. J. Immunol. 159:1997;4815-4822.
35. Kabiersch A., del Rey A., Honegger C.G., Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immunol. 2:1988;267-274.
36. Kannan H., Tanaka T., Kunitake T., Ueta Y., Hayashida Y., Yamashita H. Activation of sympathetic outflow by recombinant human interleukin-1β in conscious rats. Am. J. Physiol. 270:1996;R479-R485.
37. Katafuchi T., Take S., Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J. Physiol. 465:1993;343-357.
38. Lytle L.D., Shoemaker W.J., Cottman K., Wurtman R.J. Longterm effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels. J. Pharmacol. Exp. Ther. 183:1972;56-64.
39. Maier S.F., Watkins L.R. Cytokines for psychologists. Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105:1998;83-107.
40. Marazuela M., Vargas J.A., Alvarez-Mon M., Albarran F., Lucas T., Durantez A. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. Eur. J. Endocrinol. 132:1995;175-180.
41. Munschauer F.E., Hartrich L.A., Stewart C.C., Jacobs L. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J. Neuroimmunol. 62:1995;177-181.
42. Nonogaki K., Iguchi A., Zhu L.X., Kunoh Y., Tamagawa T., Sakamoto N. Involvement of central cholinergic muscarinic receptors and histamine H1 receptors in hyperglycemia induced by prostaglandin F2 alpha in rats. Neuroendocrinology. 57:1993;146-151.
43. G. Paxinos, C. Watson, The Rat Bain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
44. T.L. Roszman, S.L. Carlson, Neurotransmittters and molecular signalling in the immune response, in: R. Ader, D. Felten, N. Cohen, (Eds.), Psychoneuroimmunology, 2nd edn., Academic Press, New York, 1991, pp. 311-335.
45. Rothwell N.J. CRF is involved in the pyrogenic and thermogenic effects of interleukin-1β in the rat. Am. J. Physiol. 256:1989;E111-E115.
46. N.J. Rothwell, R. Dantzer, Interleukin-1 in the Brain, Pergamon, New York, 1992.
47. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system 11: actions and mechanisms of action. Trends Neurol. Sci. 18(3):1995;130-137.
48. Saperstein A., Brand H., Audhya T., Nabriski D., Hutchinson B., Rosenweig S., Hollander C.S. Interleukin-1β mediates stress-induced immunosuppression via corticotropin-releasing factor. Endocrinology. 130:1992;152-158.
49. Shintani F., Kanba S., Nakaki T., Nibuya M.et al. Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat hypothalamus. J. Neurosci. 13:1993;3547-3581.
50. Sirianni M.C., Tagliaferri F., Aiuti F. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol. Today. 11:1990;81-89.
51. Stadnyk A.W., Gauldie J. The acute phase response during parasitic infection. Immunol. Today. 12:1992;A7-A11.
52. Sundar S.K., Becker K.J., Cierpial M.A., Carpenter M.D., Rankin L.A., Fleener S.L., Ritchie J.C., Simson P.E., Weiss J.M. Intracerebroventricular infusion of interleukin-1 rapidly decreases peripheral cellular immune responses. Proc. Natl. Acad. Sci. 86:1989;6398-6402.
53. Sundar S.K., Cierpial M.A., Kilts C., Ritchie J.C., Weiss J.M. Brain IL-1 induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 10:1990;3701-3706.
54. Tranzer J.P., Thoenen H. An electron microscopic study of selective acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia. 24:1968;155-160.
55. van Gool J., van Vugt H., Helle M., Aarden L.A. The relation among stress, adrenalin, interelukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 57:1990;200-210.
56. Weiss J.M., Quan N., Sundar S.K. Widespread activation and consequences of interleukin-1 in the brain. Ann. N.Y. Acad. Sci. 741:1994;338-357.
57. R.M. Welsh, M. Vargas-Cortes, in; C.E. Lewis, J.O.D. McGee (Eds.), The Natural Killer Cell, Oxford Univ. Press, London, 1992.
58. Windebank K., Abraham R., Powis G.et al. Signal transduction during human natural killer activation: inositol phosphate generation and regulation by cyclic AMP. J. Immunol. 141:1988;3951-3957.
59. R.J. Wurtman, J. Axelrod, Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids, J. Biol. Chem., 241, 2301-2305.
60. Yamasaki K., Taga T., Hirata Y.et al. Cloning and expression of the human interleukin-6 (BSF-2/IFNb2) receptor. Science. 241:1988;825-828.
61. Yamashita M., Mieno T., Shimizu T., Yamashita E. Action of prostaglandin E2 on the release of catecholamines from the adrenal gland and its interaction with acetylcholine. J. Endocrinol. 78:1978;249-254.
62. Yokotani K., Nishihara M., Murakami Y., Hasegawa T., Okuma Y., Osumi Y. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors. Br. J. Pharmacol. 115:1995;672-676.